Both insulin sensitivity and glucose sensitivity are impaired in patients with non-diabetic liver cirrhosis

Hepatology Research

Volumn 17, Issue 2, 2000, Pages 93-101

  Kato, Masahiko ^a   Asano, Hisao ^a   Miwa, Yoshiyuki ^a,b   Tajika, Masahiro ^a   Yamato, Masahiro ^c   Tomita, Eiichi ^d   Tokuyama, Kumpei ^e   Muto, Yasutoshi ^b   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sugiyama Hum Nutr Research Center   (Japan)

^c Chuno General Hospital   (Japan)

^d Gifu Municipal Hospital   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; KINETICS; LIVER CIRRHOSIS; LIVER CLEARANCE; MALE; NUTRITIONAL SUPPORT; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0034122755     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(99)00065-0     Document Type: Article

References (29)

1. Morgan A.G., Kelleher J., Walker B.E., Losowsky M.S. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut. 17:1976;113-118.
2. Muto Y., Yoshida T., Yamato M. Clinical assessment of nutritional status in patients with liver cirrhosis with special reference to amino acid imbalance. J. Clin. Biochem. Nutr. 1:1986;89-95.
3. Freund H., Yoshimura N., Lunetta L., Fischer J.E. The role of the branched-chain amino acids in decreasing muscle catabolism in vivo. Surgery. 83:1978;611-618.
4. Yoshida Y., Muto Y., Moriwaki H., Yamato M. Effect of long term oral supplementation with branched-chain amino acid granules on the prognosis of cirrhosis. Gastroenterol. Jpn. 24:1989;692-698.
5. Megyesi C., Samols E., Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet. 2:1967;1051-1056.
6. Fischer J.E., Rosen H.M., Ebeid A.M., James J.H., Keane J.M., Soeters P.B. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 80:1976;77-91.
7. Bergman R.N., Ider Y.Z., Bowden C.R., Cobelli C. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236:1979;E667-E677.
8. Ader M., Pacini G., Yang Y.J., Bergman R.N. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal model prediction with direct measurements. Diabetes. 34:1985;1092-1103.
9. Bergman R.N., Finegood D.T., Ader M. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6:1985;45-86.
10. Bergman R.N. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 38:1989;1512-1527.
11. Blei A.T., Robbins D.C., Drobny E., Baumann G., Rubenstein A.H. Insulin resistance and insulin receptors in hepatic cirrhosis. Gastroenterology. 83:1982;1191-1199.
12. Teng C.S., Ho P.W.M., Yeung R.T.T. Down-regulation of insulin receptors in postnecrotic cirrhosis of liver. J. Clin. Endocrinol. Metab. 55:1982;524-530.
13. Proietto J., Nankervis A., Aitken P., Dudley F.J., Caruso G., Alford F.P. Insulin resistance in cirrhosis: evidence for a post-receptor defect. Clin. Endocrinol. 21:1984;677-688.
14. Marchesini G., Pacini G., Bianchi G., Patrono D., Cobelli C. Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment. Gastroenterology. 99:1990;1715-1722.
15. Letiexhe M.R., Scheen A.J., Gerard P.L. et al. Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J. Clin. Endocrinol. Metab. 77:1993;1263-1268.
16. Kruszynska Y.T., Harry D.S., Bergman R.N., McIntyre N. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia. 36:1993;121-128.
17. Kruszynska Y.T., Home P.D., McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology. 14:1991;103-111.
18. Himsworth H.P., Kerr R.B. Insulin-sensitive and insulin-insensitive types of diabetes mellitus. Clin. Sci. 4:1939;119-152.
19. Shen S.W., Reaven G.M., Farquhar J.W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and subjects with latent diabtes. J. Clin. Invest. 49:1970;2151-2160.
20. Harano Y., Ohgaku S., Hidaka H. et al. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J. Clin. Endocrinol. Metab. 45:1977;1124-1127.
21. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237:1979;E214-E223.
22. Haffner S., Stern M., Bergman R.N. Insulin resistance and increased secretion in Mexican Americans. Clin. Res. 37(Suppl.2):1989;450A.
23. Yang Y.J., Hope I.D., Bergman R.N. Insulin transport across capillaries is the rate-limiting step for insulin action. Diabetes. 38:1989;196A.
24. Ader M., Bergman R.N. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am. J. Physiol. 266:1994;E17-E25.
25. Schober O., Mariß P., Schmidt F.W., Hundeshagen H. Total body water, extracellular water, plasma volume, and total body potassium in cirrhosis of the liver. Klin. Wochenschr. 57:1979;757-761.
26. Marchesini G., Zoli M., Dondi C., Bianchi G., Cirulli M., Pisi E. Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology. 2:1982;420-425.
27. Usui T., Moriwaki H., Hatakeyama H. et al. Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis. J. Nutr. 126:1996;1412-1420.
28. Tokuyama K., Higaki Y., Fujitani J. et al. Intravenous glucose tolerance test-derived glucose effectiveness in physically trained humans. Am. J. Physiol. 265:1993;E298-E303.
29. Kawase K., Yoshida T., Moriwaki H., Muto Y. Effect of physical training on clinical and laboratory parameters in patients with compensated liver cirrhosis. Acta Hepatol. Jpn. 34:1993;950-959.